GL1X · GenesisL1 explorer

Research workbench

Understanding the role of LEU22 variants in methotrexate resistance: comparison of wild-type and LEU22ARG variant mouse and human dihydrfolate reductase ternary crystal complexes with methotrexate and NADPH

Analyse Understanding the role of LEU22 variants in methotrexate resistance: comparison… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1U72
Type
protein
Length
186 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydrofolate reductase
EC
1.5.1.3
UniProt
P00374
Ligands
NDP, MTX
Pockets
1 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 19% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydrofolate reductase (EC 1.5.1.3)protein18619% helix, 33% strandP00374

Ligands and binding sites

  • NDP · Nadph dihydro-nicotinamide-adenine-dinucleotide phosphate · ligand · chains A
  • MTX · Methotrexate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14310.740.8350NDP, MTX

Compared structures

  • 1U72 · Understanding the Role of Leu22 Variants in Methotrexate Resistance: Comparison of… · the same entry in another collection · chain A against A, TM-score 1.00
  • P00374 · AlphaFold monomer V2.0 prediction for dihydrofolate reductase (P00374) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.